Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite
Clinical trial NCT03968848 · COMPLETED
Trial details
- NCT number
- NCT03968848
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2019-03-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.